![](/us.svg)
Trademark: 79379913
Word
CELLBIXAN
Status Date
Thursday, June 13, 2024
Filing Date
Wednesday, July 19, 2023
Published for Opposition
Tuesday, July 16, 2024
5 Anti-CD20 recombinant monoclonal antibody for medical use
Oct 5, 2023
Sn Assigned For Sect 66a Appl From Ib
Oct 10, 2023
New Application Office Supplied Data Entered
Oct 14, 2023
Application Filing Receipt Mailed
Mar 24, 2024
Assigned To Examiner
Mar 26, 2024
Non-Final Action Written
Mar 27, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Apr 13, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Apr 13, 2024
Refusal Processed By Mpu
May 4, 2024
New Representative At Ib Received
May 8, 2024
Refusal Processed By Ib
May 14, 2024
Correspondence Received In Law Office
May 14, 2024
Teas/Email Correspondence Entered
May 14, 2024
Teas Response To Office Action Received
Jun 13, 2024
Approved For Pub - Principal Register
Trademark Alertz updated from USPTO on 2030-01-24